AlphAIAlphAI — Financial news for AI agents
cnbc.comOCT 62 min read$MRVL

Stocks making the biggest moves midday: Marvell, Moderna, Lamb Weston, Constellation Energy & more

Midday trading saw notable moves: memory chip stocks declined (Seagate -9.1%, Western Digital -6.9%), AI-related stocks rose (Ciena +11.3%), Moderna (-6%) and Novavax (-10%) pulled back, Vistra (+12%) after a $4.2B nuclear investment, Marvell (+) with a $20B 2028 revenue outlook, Lamb Weston (+11%) beat earnings, cybersecurity ETF (BUG) hit a high, Constellation Energy (+14%) with Google deal, Option Care (+30%) in acquisition talks, Lennar (+4%) with Berkshire Hathaway investment, AMD (+4%)…

Original reporting
cnbc.com
Published Oct 6, 2026, 5:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 5:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Stocks making the biggest moves midday: Marvell, Moderna, Lamb Weston, Constellation Energy & more — source image
Source · cnbc.com
Decision brief

The 30-second read

$MRVLBullishLow
01

Why it matters

Provides quick insight into immediate price drivers but lacks deep new information.

02

Market read

Midday price swings driven by earnings beats, guidance upgrades, and a major corporate contract.

03

What to watch

Potential supply‑chain constraints for AI chips and regulatory risk for biotech.

Relevance 4/10Novelty 2/10Timing: midday trading

Background

The article is a midday market roundup summarizing the biggest price moves and key catalysts for a set of U.S. listed stocks.

Company-level read

Ticker impact

$MRVLBullishHigh confidence
Context

Marvell jumped after rolling out a rosy long‑term revenue outlook at its Investor Day.

Expected impact

likely upside as market prices in higher revenue expectations.

Evidence & confidence

Guidance above consensus can drive buying pressure today.

$MRNABearishMedium confidence
Context

Moderna fell 6% despite recent gains, indicating a pull‑back in the stock.

Expected impact

potential further pressure if pull‑back continues.

Evidence & confidence

Move appears reactionary; no fresh news to sustain direction.

$LWBullishHigh confidence
Context

Lamb Weston rose more than 11% after reporting Q1 earnings that beat expectations.

Expected impact

likely continued buying as earnings beat fuels optimism.

Evidence & confidence

Beating consensus and raising guidance are strong short‑term drivers.

$CEGBullishHigh confidence
Context

Constellation Energy jumped 14% after Alphabet announced a long‑term power purchase agreement.

Expected impact

upward pressure as market values the new revenue stream.

Evidence & confidence

A multi‑billion‑dollar power deal is a material catalyst.

Market effects

Sector

Highlights strength in AI‑related chips and biotech volatility.

Regional

U.S. equities showed mixed reactions across sectors.

Global

Limited to U.S. listed companies; no broader macro impact.

Counterpoint

What could challenge this read

Some moves may be over‑reactive; fundamentals could be weaker than price suggests.

Key entities

  • company
    Marvell Technology

    Chipmaker with upgraded revenue outlook.

  • company
    Moderna

    Biotech firm experiencing a short‑term pull‑back.

  • company
    Lamb Weston

    Potato‑product producer beating Q1 earnings.

  • company
    Constellation Energy

    Energy firm securing a power purchase deal with Alphabet.

Read at source← All news

Related articles

OCT 8
$CEGMed

Big Tech Keeps Signing Nuclear Deals With the Same Company. Here's Who It Is and Why That Matters More Than Any Single Deal.

Constellation Energy (CEG) signed a deal with Alphabet's Google to supply 890 MW of nuclear power, highlighting its role in powering AI growth for tech giants. CEG operates outside regulated utilities, offering direct power sales to companies like Microsoft, Meta, and Amazon. Its scale, diverse energy portfolio, and long-term contracts support growth, though its stock remains 25% below 2025 highs.

aol.com2 min
OCT 8
$LWHighAI 9/10

Lamb Weston starts new fiscal year strong

Lamb Weston reported a 5% increase in North American sales to $1.14B for Q1 2027, offsetting international declines and inflation pressures. EBITDA fell 5%, but the company raised its fiscal 2027 outlook, expecting adjusted EBITDA of $1.125B-$1.215B and over 1% net sales growth. Cash reserves rose to $166M by Aug. 30.

tricitiesbusinessnews.com2 min
OCT 7
$MUMed

Memory Trade: Cyclical or Durable Growth?

Micron (MU) and SanDisk (SNDK) have surged due to AI-driven demand, with gains of 953% and 3,398.70% over two years. Despite strong earnings and guidance, both stocks have recently stagnated amid debates over cyclicality. DA Davidson raised Micron's price target to $3,000, citing investor sentiment. Analysts expect Micron's earnings to rise 699% next quarter, with supply constraints lasting until 2027. Both stocks have a P/E of 13.85x.

finviz.com3 min
OCT 7
$CEGMed

Constellation, Vistra uprate deals signal fastest path to new nuclear megawatts

Constellation Energy, Google, and the U.S. DOE announced a 20-year power purchase agreement for 890 MW of nuclear uprates at 11 reactors, with Constellation investing $4.3B. The DOE also committed up to $4.2B for Vistra's nuclear upgrades, adding 433 MW of capacity. Both deals aim to boost existing nuclear capacity to meet rising electricity demand, particularly in the PJM Interconnection.

power-eng.com2 min
OCT 7
$MRNAHigh

MRNA Jumps As Nasdaq-100 Inclusion And Cancer Pipeline Shift Momentum

Moderna Inc. (MRNA) shares rose 4.78% on October 7, 2026, driven by positive mRNA pipeline data and upcoming inclusion in the Nasdaq-100 index. The company reported quarterly revenue of $1.92B, but with significant losses. Traders are watching MRNA for its potential as a growth platform with catalysts like the index inclusion and cancer vaccine developments.

stockstotrade.com3 min
OCT 7
$MRNAHighAI 8/10

MRNA Stock Jumps As Nasdaq-100 Inclusion Ignites Momentum

Moderna Inc. (MRNA) stock rose 4.82% after being added to the Nasdaq-100 index. The company reported a net loss of $782M but has strong cash reserves. Positive data for its cancer vaccine and a new COO appointment also influenced trading. MRNA's stock has been volatile, with a recent uptrend and a 6-7% drop on the management change news.

timothysykes.com2 min